MX338100B - Celulas derivadas de tejido cardiaco. - Google Patents

Celulas derivadas de tejido cardiaco.

Info

Publication number
MX338100B
MX338100B MX2012000493A MX2012000493A MX338100B MX 338100 B MX338100 B MX 338100B MX 2012000493 A MX2012000493 A MX 2012000493A MX 2012000493 A MX2012000493 A MX 2012000493A MX 338100 B MX338100 B MX 338100B
Authority
MX
Mexico
Prior art keywords
derived cells
cardiac tissue
compositions
present
human cardiac
Prior art date
Application number
MX2012000493A
Other languages
English (en)
Other versions
MX2012000493A (es
Inventor
Xiaozhen Wang
Ian R Harris
Jeffrey S Kennedy
Jing Yang
Susan Munga
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of MX2012000493A publication Critical patent/MX2012000493A/es
Publication of MX338100B publication Critical patent/MX338100B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La presente invención se refiere a métodos y composiciones para reparar el miocardio dañado con el uso de células derivadas de tejido cardíaco humano; particularmente, la presente invención proporciona métodos y composiciones para reparar el miocardio dañado con el uso de células derivadas de tejido cardíaco humano expandidas que no expresan telomerasa.
MX2012000493A 2009-07-09 2010-07-08 Celulas derivadas de tejido cardiaco. MX338100B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22444609P 2009-07-09 2009-07-09
PCT/US2010/041327 WO2011005930A1 (en) 2009-07-09 2010-07-08 Cardiac tissue-derived cells

Publications (2)

Publication Number Publication Date
MX2012000493A MX2012000493A (es) 2012-06-01
MX338100B true MX338100B (es) 2016-04-01

Family

ID=43429532

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012000493A MX338100B (es) 2009-07-09 2010-07-08 Celulas derivadas de tejido cardiaco.

Country Status (17)

Country Link
US (2) US20110014161A1 (es)
EP (1) EP2451941B1 (es)
JP (1) JP5894071B2 (es)
KR (1) KR101834800B1 (es)
CN (1) CN102712897B (es)
AR (1) AR077309A1 (es)
AU (1) AU2010271394B9 (es)
BR (1) BR112012001107A2 (es)
CA (1) CA2767825A1 (es)
ES (1) ES2679271T3 (es)
MX (1) MX338100B (es)
PH (1) PH12011502641A1 (es)
PL (1) PL2451941T3 (es)
RU (3) RU2583287C2 (es)
SG (2) SG176806A1 (es)
WO (1) WO2011005930A1 (es)
ZA (1) ZA201200949B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9644181B2 (en) * 2012-04-25 2017-05-09 Riken Cell preparation containing myocardium-committed cell
GB201304831D0 (en) 2013-03-15 2013-05-01 Coretherapix Slu Adult cardiac stem cell population
US20140271575A1 (en) * 2013-03-15 2014-09-18 Coretherapix Slu Adult cardiac stem cell population
EP2875819B1 (en) 2013-11-20 2018-09-19 Miltenyi Biotec GmbH Compositions of cardiomyocyte subpopulations
US20150328263A1 (en) 2014-05-14 2015-11-19 University Of Maryland, Baltimore Cardiac stem cells for cardiac repair
KR20250043178A (ko) * 2023-09-21 2025-03-28 주식회사 티앤알바이오팹 심실 심근세포 정제 및 제조 방법

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0372872A (ja) * 1988-07-12 1991-03-28 Bio Kagaku Kenkyusho:Kk 無血清培地及びそれを用いた哺乳類細胞の培養法
US5958680A (en) * 1994-07-07 1999-09-28 Geron Corporation Mammalian telomerase
US5919449A (en) * 1995-05-30 1999-07-06 Diacrin, Inc. Porcine cardiomyocytes and their use in treatment of insufficient cardiac function
EP0841396B2 (en) * 1996-10-01 2012-04-11 Geron Corporation Human telomerase catalytic subunit
US6331406B1 (en) * 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
EP1064356A2 (en) * 1998-03-23 2001-01-03 ZymoGenetics, Inc. Cardiac-derived stem cells
US6667176B1 (en) * 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
JP2000281593A (ja) * 1999-03-30 2000-10-10 Fuji Photo Film Co Ltd 精製有機化合物の製造方法
US20030161817A1 (en) * 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US20030129745A1 (en) * 1999-10-28 2003-07-10 Robl James M. Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
JP2002078483A (ja) * 2000-06-28 2002-03-19 Takeda Chem Ind Ltd 心筋細胞の調製法および心疾患治療薬の探索法
US20020061587A1 (en) * 2000-07-31 2002-05-23 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
EP1367899A4 (en) * 2001-02-14 2004-07-28 Leo T Furcht TOTIPOTENT ADULT STEM CELLS, SOURCES OF SUCH CELLS, METHODS FOR OBTAINING AND MAINTAINING SAME, METHODS FOR DIFFERENTIATING THESE CELLS, METHODS OF USING SAME, AND CELLS DERIVED FROM THE ABOVE-MENTIONED CELLS
US20030082153A1 (en) * 2001-10-22 2003-05-01 The Government Of The United States Of America Stem cells that transform to beating cardiomyocytes
WO2003042405A2 (en) * 2001-11-15 2003-05-22 Children's Medical Center Corporation Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
US20050281788A1 (en) * 2002-07-30 2005-12-22 Cosimo De Bari Compositions comprising muscle progenitor cells and uses thereof
WO2004019767A2 (en) * 2002-08-29 2004-03-11 Baylor College Of Medicine Heart derived cells for cardiac repair
ITRM20030376A1 (it) * 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
CN103602633A (zh) * 2003-10-03 2014-02-26 福田惠一 由干细胞分化诱导心肌细胞的方法
AU2005273077B2 (en) * 2004-08-16 2011-02-24 Cellresearch Corporation Pte Ltd Isolation of stem/progenitor cells from amniotic membrane of umbilical cord.
US7527971B2 (en) * 2004-10-20 2009-05-05 Vitro Diagnostics, Inc. Adult stem cell lines
GB0501129D0 (en) * 2005-01-19 2005-02-23 Ribostem Ltd Method of treatment by administration of RNA
US20080241111A1 (en) * 2005-03-04 2008-10-02 Kyoto University Pluripotent Stem Cell Derived from Cardiac Tissue
US20070093748A1 (en) * 2005-06-23 2007-04-26 Medtronic Vascular, Inc. Methods and systems for treating injured cardiac tissue
JPWO2007010858A1 (ja) * 2005-07-15 2009-01-29 国立大学法人京都大学 骨格筋組織由来の単一細胞よりクローン化した多能性幹細胞
US20070054397A1 (en) * 2005-08-26 2007-03-08 Harald Ott Adult cardiac uncommitted progenitor cells
US20080070303A1 (en) * 2005-11-21 2008-03-20 West Michael D Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby
RU2308982C2 (ru) * 2005-12-08 2007-10-27 ГУ Научно-исследовательский институт кардиологии Томского научного центра Сибирского отделения Российской академии медицинских наук ГУ НИИ кардиологии ТНЦ СО РАМН Способ лечения больных ишемической болезнью сердца, перенесших инфаркт миокарда
FR2896511B1 (fr) * 2006-01-26 2012-10-26 Centre Nat Rech Scient Procede de culture de cellules issues du tissu adipeux et leurs applications.
EP1991664B1 (en) * 2006-02-16 2018-03-28 Ospedale San Raffaele S.r.l. Skeletal muscle periangioblasts and cardiac mesangioblasts, method for isolation and uses thereof
US20080050347A1 (en) * 2006-08-23 2008-02-28 Ichim Thomas E Stem cell therapy for cardiac valvular dysfunction
WO2008058216A2 (en) * 2006-11-07 2008-05-15 Keck Graduate Institute Enriched stem cell and progenitor cell populations, and methods of producing and using such populations

Also Published As

Publication number Publication date
BR112012001107A2 (pt) 2015-09-01
US20160346331A1 (en) 2016-12-01
AU2010271394A1 (en) 2012-01-19
SG176806A1 (en) 2012-01-30
CN102712897A (zh) 2012-10-03
ES2679271T3 (es) 2018-08-23
JP2012532609A (ja) 2012-12-20
KR101834800B1 (ko) 2018-03-06
KR20120041212A (ko) 2012-04-30
PL2451941T3 (pl) 2018-10-31
EP2451941B1 (en) 2018-06-13
AU2010271394B9 (en) 2015-09-24
JP5894071B2 (ja) 2016-03-23
ZA201200949B (en) 2018-11-28
RU2662675C1 (ru) 2018-07-26
CN102712897B (zh) 2018-07-10
RU2012104553A (ru) 2013-08-20
AR077309A1 (es) 2011-08-17
PH12011502641A1 (en) 2012-11-12
RU2583287C2 (ru) 2016-05-10
MX2012000493A (es) 2012-06-01
EP2451941A4 (en) 2013-06-19
WO2011005930A1 (en) 2011-01-13
US20110014161A1 (en) 2011-01-20
AU2010271394B2 (en) 2015-09-17
EP2451941A1 (en) 2012-05-16
SG10201406427PA (en) 2014-11-27
CA2767825A1 (en) 2011-01-13
RU2642282C1 (ru) 2018-01-24

Similar Documents

Publication Publication Date Title
HUS2500003I1 (hu) Módosított IX-es faktor, valamint készítmények, eljárások és alkalmazások sejtekbe, szervekbe és szövetekbe történõ géntranszferhez
WO2010111409A3 (en) Pluripotent stem cells
WO2013070881A8 (en) Method for elimination of space through tissue approximation
MX2012005782A (es) Procedimientos, composiciones y kits de liofilizacion.
CO6561839A2 (es) Alteracion genómica dirigida
WO2011139688A3 (en) Methods for generating cardiomyocytes
WO2012048010A3 (en) Compositions of adult organ stem cells and uses thereof
MY193806A (en) Affinity-oligonucleotide conjugates and uses thereof
WO2015002724A3 (en) SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
MX2013009175A (es) Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.
IN2012DN00581A (es)
MX2012011543A (es) Tratamiento de sarcoidosis empleando celulas madre placentarias.
ZA201202685B (en) Methods of preparing mesenchymal stem cells,compositions and kit thereof
SG11201405875PA (en) Methods and compositions for regenerating and repairing damaged tissue using nonviable irradiated or lyophilized pluripotent stem cells
WO2010141417A3 (en) Systems and methods for impairing smooth muscle tissue function
PT3551748T (pt) Células estaminais do mesênquima derivadas de tecido perinatal: método de preparação e suas utilizações
MX2013004123A (es) Composiciones antitusigenas que comprenden memantina.
MX2009010049A (es) Metodos y composiciones para promover la salud de huesos y articulaciones.
MX388960B (es) Una población de células madre mesenquimales enriquecida en integrina a10alta y su uso en la prevención y tratamiento de daño o enfermedad ósea y cartílago.
PH12012500740A1 (en) Nutritional compositions including a high protein component and exogenous nucleotides
WO2011100286A3 (en) Compositions and methods of generating a differentiated mesodermal cell
WO2012003465A3 (en) Scaffold-free three dimensional nerve fibroblast constructs
MX356178B (es) Uso de azucares en matriz de estabilizacion y composiciones solidas.
MY161601A (en) Films and compositions comprising the same
MX338100B (es) Celulas derivadas de tejido cardiaco.

Legal Events

Date Code Title Description
FG Grant or registration